BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

SHENKMAN CAPITAL MANAGEMENT INC's Holding History (CIK: 0001275228)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 16,732,000 Value ($000) $16,408 Avg Close — Range —
Q2 2023
Shares 19,413,000 Value ($000) $19,246 Avg Close — Range —
Q1 2023
Shares 23,984,000 Value ($000) $24,566 Avg Close — Range —
Q4 2022
Shares 30,334,000 Value ($000) $32,181 Avg Close — Range —
Q3 2022
Shares 28,381,000 Value ($000) $28,116 Avg Close — Range —
Q2 2022
Shares 29,791,000 Value ($000) $29,160 Avg Close — Range —
Q1 2022
Shares 30,138,000 Value ($000) $29,510 Avg Close — Range —
Q4 2021
Shares 30,692,000 Value ($000) $31,428 Avg Close — Range —
Q3 2021
Shares 33,796,000 Value ($000) $34,381 Avg Close — Range —
Q2 2021
Shares 27,278,000 Value ($000) $28,508 Avg Close — Range —
Q1 2021
Shares 27,562,000 Value ($000) $28,071 Avg Close — Range —
Q4 2020
Shares 26,959,000 Value ($000) $29,149 Avg Close — Range —
Q3 2020
Shares 25,291,000 Value ($000) $26,805 Avg Close — Range —
Q2 2020
Shares 22,185,000 Value ($000) $27,393 Avg Close — Range —
Q1 2020
Shares 20,815,000 Value ($000) $21,912 Avg Close — Range —
Q4 2019
Shares 20,916,000 Value ($000) $22,305 Avg Close — Range —
Q3 2019
Shares 24,674,000 Value ($000) $24,447 Avg Close — Range —
Q2 2019
Shares 25,929,000 Value ($000) $27,077 Avg Close — Range —
Q1 2019
Shares 25,885,000 Value ($000) $26,548 Avg Close — Range —
Q4 2018
Shares 26,902,000 Value ($000) $26,819 Avg Close — Range —
Q3 2018
Shares 25,130,000 Value ($000) $26,845 Avg Close — Range —
Q2 2018
Shares 16,370,000 Value ($000) $16,578 Avg Close — Range —
Q1 2018
Shares 16,298,000 Value ($000) $15,340 Avg Close — Range —
Q4 2017
Shares 16,159,000 Value ($000) $16,139 Avg Close — Range —